Correlation Between Viridian Therapeutics and General Motors

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and General Motors at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and General Motors into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and General Motors Co, you can compare the effects of market volatilities on Viridian Therapeutics and General Motors and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of General Motors. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and General Motors.

Diversification Opportunities for Viridian Therapeutics and General Motors

-0.29

Correlation Coefficient

Viridian Therapeutics  General Motors

Very good diversification

The 3 months correlation between Viridian and General is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and General Motors Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on General Motors and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with General Motors. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of General Motors has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and General Motors go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and General Motors

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the General Motors. In addition to that, Viridian Therapeutics is 2.57 times more volatile than General Motors Co. It trades about -0.06 of its total potential returns per unit of risk. General Motors Co is currently generating about 0.01 per unit of volatility. If you would invest  5,264  in General Motors Co on September 26, 2024 and sell it today you would earn a total of  6.00  from holding General Motors Co or generate 0.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  General Motors Co

Viridian Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

General Motors

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in General Motors Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, General Motors unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Viridian Therapeutics and General Motors

The main advantage of trading using opposite Viridian Therapeutics and General Motors positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, General Motors can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in General Motors will offset losses from the drop in General Motors' long position.

The idea behind Viridian Therapeutics and General Motors Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..